Tivic Health Systems

Tivic Health Systems, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company was founded by Jennifer Ernst and John Claude on September 22, 2016 and is headquartered in Hayward, CA.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Tivic Health Systems reports revenue growth and strategic advancements in Q1 2024

Tivic Health Systems showcased revenue growth and strategic initiatives in their Q1 2024 earnings call, emphasizing progress in bioelectronic medicine and clinical studies.
While facing challenges in managing a net loss and optimizing sales dynamics, the company's strengths lie in fiscal responsibility, product innovation, and market expansion.
Opportunities abound for Tivic Health to capitalize on their VNS program success, ClearUp product momentum, and strategic funding for future growth and value creation.
By balancing financial discipline with innovation, Tivic Health aims to navigate challenges, leverage strengths, and seize opportunities for sustainable growth and market leadership.

Tivic Health Systems advances VNS technology amidst financial challenges

Tivic Health Systems is making strides in VNS technology development and clinical research, despite facing financial and compliance challenges. With a strong patent portfolio and a focus on innovation, the company is well-positioned to capitalize on emerging opportunities in the medical device market.

Tivic Health Systems navigates challenges, eyes growth in VNS market

Tivic Health Systems faces financial challenges but shows resilience through strategic focus on profitability, innovation, and operational efficiency.
The company's progress in the VNS program and market assessment efforts position it well for future growth and market expansion opportunities.
With a new CFO onboard and a proactive approach to addressing product challenges, Tivic Health is poised to navigate challenges and capitalize on growth prospects.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tivic Health Systems, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company was founded by Jennifer Ernst and John Claude on September 22, 2016 and is headquartered in Fremont, CA.

Tivic Health Systems (NASDAQ: TIVC ) stock is falling on Thursday after revealing pricing for a public stock offering. The company has priced shares of TIVC stock at 25 cents each.

Why Is Tivic Health Systems (TIVC) Stock Down 51% Today

SAN FRANCISCO--(BUSINESS WIRE)---- $TIVC #healthcare--Tivic Health® Systems, Inc. (“Tivic”) (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced the pricing of an underwritten public offering of an aggregate of 20,000,000 shares of common stock. Each share is being sold to the public at a price of $0.25 per share, for aggregate gross proceeds of approximately $5,000,000, before deducting underwriting discounts and offering expenses.

Tivic Health Systems, Inc. Announces Pricing of Public Offering

SAN FRANCISCO--( BUSINESS WIRE )--Tivic Health® Systems, Inc. (“Tivic”) (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that Global Health & Pharma (GHP) has named Tivic Health the Most Pioneering Bioelectronic Medicine Company of 2022.

Tivic Health Named Most Pioneering Bioelectronic Medicine Company by Global Health & Pharma Magazine

Tivic Health Systems, Inc. (TIVC) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Here's Why Tivic Health Systems, Inc. (TIVC) Looks Ripe for Bottom Fishing

SAN FRANCISCO--( BUSINESS WIRE )--Tivic Health® Systems, Inc. (“Tivic”) (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that Tivic Health and Reliefband Technologies, LLC have, by mutual agreement, terminated the parties' agreement for the acquisition of the Reliefband product line and related assets entered into on October 7, 2022. Information regarding the termination is contained in the company's Current Report on Form 8-K filed with the SEC.

Tivic Health and Reliefband Technologies, LLC Terminate Acquisition Agreement

SAN FRANCISCO--( BUSINESS WIRE )--Tivic Health® Systems, Inc. (“Tivic”) (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced it has hired ALOM Technologies Corporation (“ALOM”), a leader in global supply chain product and service delivery programs, to manage product supply chain, assembly, and logistics.

Tivic Health Signs Agreement with ALOM to Manage Product Supply Chain, Assembly, and Logistics

SAN FRANCISCO--( BUSINESS WIRE )--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced its financial results for the quarter ended September 30, 2022.

Tivic Health Reports Third Quarter 2022 Financial Results

SAN FRANCISCO--(BUSINESS WIRE)---- $TIVC #healthcare--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company focused on bioelectronic medicine, today announced it has entered into an agreement with Microart Services Inc., headquartered in Buffalo, New York, to manufacture, on a non-exclusive basis, certain components and sub-assemblies of the company's current and future products.

Tivic Health Announces Manufacturing Partnership With Microart

SAN FRANCISCO--(BUSINESS WIRE)---- $TIVC #healthcare--Tivic Health® Systems, Inc. (Nasdaq: TIVC) (“Tivic Health”), a commercial-phase health technology company focused on bioelectronic medicine, is bringing bioelectronic medicine to HTLH with ClearUP, an FDA-approved and clinically proven device that uses low-level electrical stimulation to treat sinus pain and congestion from allergies, colds, and flu.

Tivic Health Takes Bioelectronic Medicine to HTLH

SAN FRANCISCO--(BUSINESS WIRE)---- $TIVC #healthcare--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that it will report financial results for the third quarter of 2022 via conference call and webcast on Monday, November 14, 2022, at 1:30 PM PT / 4:30 PM ET.

Tivic Health to Report Third Quarter 2022 Financial Results on Monday, November 14th

SAN FRANCISCO--(BUSINESS WIRE)---- $TIVC #healthcare--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that the company's CEO will present at The ThinkEquity Conference to be held on Wednesday, October 26 in New York City.

Tivic Health's CEO, Jennifer Ernst, to Present at Upcoming ThinkEquity Conference in New York City

SAN FRANCISCO--(BUSINESS WIRE)---- $TIVC #healthcare--Tivic Health® Systems, Inc. (Nasdaq: TIVC) (“Tivic Health”), a commercial-phase health technology company focused on bioelectronic medicine, today announced it has entered into a definitive agreement to acquire the Reliefband product line for nausea treatment and all related assets from Reliefband Technologies, LLC.

Tivic Health to Acquire Assets of Reliefband

SAN FRANCISCO--(BUSINESS WIRE)---- $TIVC #healthcare--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that the company's CEO will present at Fifth Bioelectronic Medicine Summit – Bioelectronic Medicine: Today's Tools, Tomorrow's Therapies organized by the Feinstein Institutes for Medical Research and the Columbia University School of Engineering. In Session 7 of the event, Jennifer Ernst will sit alongsi

Tivic Health's CEO, Jennifer Ernst, to Speak at Fifth Bioelectronic Medicine Summit - Bioelectronic Medicine: Today's Tools, Tomorrow's Therapies

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that the company's CEO will present at the upcoming 148th National Investment Banking Association conference. WHO: Jennifer Ernst, Chief Executive Officer WHAT: The National Investment Banking Association Conference WHERE: Margaritaville Beach Resort   1111 N. Ocean Drive, Hollywood, FL 33019 WHEN: Septe

Tivic Health's CEO Invited to Present at the 148th National Investment Banking Association Conference

SAN FRANCISCO--(BUSINESS WIRE)---- $TIVC #healthcare--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced its financial results for the quarter ended June 30, 2022. Jennifer Ernst, CEO of Tivic Health commented, “Our second quarter results demonstrate clear traction on the three pillars of the strategy we laid out last November – increasing direct-to-consumer revenue, reducing cost of goods a

Tivic Health Reports Strong Growth in Second Quarter 2022 Financial Results

SAN FRANCISCO--(BUSINESS WIRE)---- $TIVC #healthcare--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that it will report financial results for the second quarter of 2022 via conference call and webcast, Monday, August 15, 2022, at 1:30 pm PT / 4:30 pm ET. Teleconference Details: Toll-Free: 877-545-0320 International: 973-528-0002 Participant Access Code: 492379 Webcast Link: https://www.webcaster4.com/W

Tivic Health to Report Second Quarter 2022 Earnings on August 15 Via Conference Call and Webcast

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that for the second consecutive year ClearUP® Sinus Pain Relief has received Global Health & Pharma's 2022 award for Most Innovative Sinus Relief Solution. ClearUP is a small handheld device that is FDA-cleared, CE marked, and clinically proven to provide relief from sinus pain and congestion from al

Tivic Health Receives Second Global Health & Pharma Award: ClearUP Named 2022 Most Innovative Sinus Relief Solution

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced the Annual General Meeting of Shareholders will be held on Tuesday, June 14, 2022, at 10:00 a.m., Pacific Daylight Time. The Company has adopted a virtual format for our Annual Meeting to provide a healthy, consistent, and convenient experience for all stockholders regardless of location. WHEN: Tuesday,

Tivic Health Announces Annual Meeting of Shareholders

SAN FRANCISCO , May 25, 2022 /PRNewswire/ -- Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced survey findings revealing that seasonal allergies impact job performance, commuting, and the ability to enjoy outdoor activities. A randomized survey of 2,000 U.S. allergy sufferers* was conducted last month by OnePoll on behalf of Tivic Health and found that 79 percent of respondents look forward to the changing seasons, but not the potential allergies that come with it.

Tivic Health Survey Reveals Allergy Season Impacts Job Performance, Commuting, and Ability to Enjoy Outdoor Activities

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced its financial results for the quarter ended March 31, 2022. “I am pleased that our strategy to grow direct-to-consumer sales is driving both our revenue growth and increased gross margins. Increasing sales through direct-to-consumer channels is the first cornerstone in the strategic plan

Tivic Health Reports First Quarter 2022 Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Jennifer Ernst, CEO of Tivic Health® Systems, Inc. (Nasdaq: TIVC), is an invited speaker at FORTUNE Brainstorm Health and will participate on the panel Driving Digital Health: Where Wearables Are Headed Next. The session will take place on May 11 and panelists will include Robert Ford, chairman and CEO, Abbott and Adrian Aoun, founder and CEO, Forward. Phil Wahba, senior writer, FORTUNE will moderate. FORTUNE Brainstorm Health will take place May 10-11, 2022, in

Tivic Health CEO Jennifer Ernst to Speak at Fortune Brainstorm Health

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that it will report financial results for the first quarter of 2022 via conference call and webcast, Monday, May 16, 2022, at 1:30 pm PT / 4:30 pm ET. Teleconference Details: Toll Free: 888-506-0062 International: 973-528-0011 Participant Access Code: 535202 Webcast Link: https://www.webcaster4.com/Webca

Tivic Health to Report First Quarter 2022 Earnings on May 16th Via Conference Call and Webcast

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc., (Nasdaq: TIVC) (“Tivic Health” or the “Company”) a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that financial results for the fourth quarter of 2021 and the year-end shareholder update will take place via conference call on Tuesday, April 19, 2022, at 2:00 pm PT / 5:00 pm ET. Conference Call Information: April 19, 2022 at 2:00 pm PT / 5:00 pm ET Teleconference Tol

Tivic Health to Report 2021 Fourth Quarter & Year-End Shareholder Update on Tuesday, April 19

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc., (Nasdaq: TIVC) (“Tivic Health” or the “Company”), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced key executive appointments. Veronica Cai has joined the Company as chief financial officer effective April 1, 2022, Ryan Sabia was promoted to chief operating officer in December 2021, and Sanjay Ahuja, Ph.D. has joined as senior vice president, quality assurance &

Tivic Health Announces Key Executive Appointments Strengthening Leadership Team

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health's ClearUP named Best Sinus Pain Relief Solution of 2021 by Global Health & Pharma Magazine.

News for Tivic Health Systems Stock (TIVC)